Drawing for LAPAS

USPTO serial 79302106

LAPAS

Reviewed by CopyMark Law Group

Reg. 6688541Status 700Registered
Filing date
Status date
Registration date
Apr 5, 2022
Examiner
LAM, HAI-LY HUYNH
Law office
PUBLICATION AND ISSUE SECTION

What this means

Status 700 means the trademark is registered and active on the Principal Register. You have nationwide rights for the listed goods and services and may use ®. Section 8 maintenance is due between years five and six. Calendar Section 8 between years five and six, and consider trademark monitoring.

Status 700: Status 700 means the trademark is registered and active on the Principal Register. You have nationwide rights for the listed goods and services and may use ®. Section 8 maintenance is due between years five and six.

Need help with LAPAS?

If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.

Current trademark owner
Monitor this mark, or talk with CopyMark about this registration.
Not the owner?
File a new U.S. trademark application, or speak with our attorneys.

Owner

Goods and services

ClassDescriptionStatusFirst use
010Apparatus and devices for administering pharmaceuticals and drugs, namely, patch infusion pumps sold without medication, drug delivery patches sold without medication; mobile apparatus and devices for administering pharmaceuticals and drugs, namely, patch infusion pumps sold without medication, drug delivery patches sold without medication; apparatus and devices for administering pharmaceuticals and drugs which can be worn by the patient, namely, medical apparatus in the nature of infusion and injection devices for administering drugs, medical tubing for administering drugs; medical syringes; syringe stoppers specially adapted for medical syringes; medical fluid auto-injectors; medical fluid injectors; disposable syringes and medical fluid injectors; hypodermic syringes and medical fluid injectors; sterile apparatus for the administration of pharmaceuticals and drugs, namely, medical apparatus in the nature of infusion and injection devices for administering drugs, medical tubing for administering drugs, hypodermic needles; cartridges specially adapted for medical syringes; nozzles specially adapted for medical syringes; drug delivery apparatus, namely, drug delivery catheters, implantable drug delivery pumps, electromagnetic drug delivery apparatus for medical use in the form of patch infusion pumps sold without medication and in the form of patch insulin pumps sold without medication; oral and nasal medication dispensers, namely, aerosol dispensers for medical use; aerosol dispensers for medical purposes; structural replacement parts and fittings for all the aforesaid goodsACTIVE

Related trademarks

CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.

Prosecution history

DateCodeEventWhat it means
Dec 11, 2025NREPNEW REPRESENTATIVE AT IB RECEIVED
Feb 29, 2024RNWLINTERNATIONAL REGISTRATION RENEWED
Nov 22, 2022NREPNEW REPRESENTATIVE AT IB RECEIVED
Sep 20, 2022FINOFINAL DECISION TRANSACTION PROCESSED BY IB
Aug 25, 2022FICSFINAL DISPOSITION NOTICE SENT TO IB
Aug 25, 2022FIMPFINAL DISPOSITION PROCESSED
Jul 5, 2022FICRFINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB
Apr 5, 2022R.PRREGISTERED-PRINCIPAL REGISTERYour trademark is registered on the Principal Register — the strongest form of federal trademark protection. You may use the ® symbol for the covered goods and services. Maintenance filings (Section 8 and renewals) are required to keep the registration alive.
Jan 29, 2022GPNXNOTIFICATION PROCESSED BY IB
Jan 18, 2022NPUBOFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Jan 18, 2022PUBOPUBLISHED FOR OPPOSITIONYour mark was published in the USPTO Official Gazette for a 30-day opposition window. During that period, third parties who believe they would be harmed can file an opposition. If no opposition is filed, prosecution usually continues toward registration or a Notice of Allowance.
Dec 29, 2021OPNSNOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB
Dec 29, 2021OP2RNOTICE OF START OF OPPOSITION PERIOD CREATED, TO BE SENT TO IB
Dec 29, 2021NONPNOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Dec 13, 2021CNSAAPPROVED FOR PUB - PRINCIPAL REGISTER
Nov 24, 2021XAECEXAMINER'S AMENDMENT ENTERED
Nov 24, 2021GNENNOTIFICATION OF EXAMINERS AMENDMENT E-MAILED
Nov 24, 2021GNEAEXAMINERS AMENDMENT E-MAILED
Nov 24, 2021CNEAEXAMINERS AMENDMENT -WRITTEN
Nov 23, 2021TEMETEAS/EMAIL CORRESPONDENCE ENTERED
Nov 23, 2021CRFACORRESPONDENCE RECEIVED IN LAW OFFICE
Nov 23, 2021ERFRTEAS REQUEST FOR RECONSIDERATION RECEIVED
Aug 4, 2021GNFNNOTIFICATION OF FINAL REFUSAL EMAILED
Aug 4, 2021GNFRFINAL REFUSAL E-MAILEDA final Office Action (final refusal) means the examining attorney is maintaining at least one refusal and your options are narrower. You can file a response addressing the refusal, appeal to the Trademark Trial and Appeal Board, or let the application abandon.
Aug 4, 2021CNFRFINAL REFUSAL WRITTENA final Office Action (final refusal) means the examining attorney is maintaining at least one refusal and your options are narrower. You can file a response addressing the refusal, appeal to the Trademark Trial and Appeal Board, or let the application abandon.
Jul 11, 2021RFNTREFUSAL PROCESSED BY IB
Jul 9, 2021TEMETEAS/EMAIL CORRESPONDENCE ENTERED
Jul 9, 2021CRFACORRESPONDENCE RECEIVED IN LAW OFFICE
Jul 9, 2021TROATEAS RESPONSE TO OFFICE ACTION RECEIVEDThis event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action.
Jun 15, 2021RFCSNON-FINAL ACTION MAILED - REFUSAL SENT TO IB
Jun 15, 2021RFRRREFUSAL PROCESSED BY MPU
Jun 11, 2021RFCRNON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW
Jun 10, 2021CNRTNON-FINAL ACTION WRITTENA non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application.
Jun 7, 2021DOCKASSIGNED TO EXAMINER
Jan 15, 2021MAFRAPPLICATION FILING RECEIPT MAILED
Jan 11, 2021NWOSNEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Jan 7, 2021SDRCSN ASSIGNED FOR SECT 66A SUBSEQ DESIG FROM IB

Frequently asked questions

Related guidance